Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998

Journal of Clinical Microbiology

Volumn 40, Issue 7, 2002, Pages 2648-2650

  Verweij, Paul E ^a   Te Dorsthorst, Debbie T A ^a   Rijs, Anthonius J M M ^a   De Vries Hospers, Hilly G ^a   Meis, Jacques F G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, FUNGAL; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PYRIMIDINES; TIME FACTORS; TRIAZOLES;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

EID: 0036305717     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.7.2648-2650.2002     Document Type: Article

References (17)

1. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial
2. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
3. Acquired itraconazole resistance in Aspergillus fumigatus
4. Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters
5. Itraconazole resistance in Aspergillus fumigatus
6. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
7. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi
8. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing of filamentous fungi
9. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
10. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NC-CLS collaborative evaluation
11. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
12. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis{2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide}, for antifungal susceptibility testing of Aspergillus species
13. Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14α-demethylase gene, pdmA
14. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program
15. Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices
16. Improvement of the straw technique for the preservation of fungi in liquid nitrogen